Medtronic announces scientific data presentations at the 14th international conference on advanced technologies & treatments for diabetes

Data on the company's holistic portfolio will include real-world data on   minimed™ 780g system and new data on medtronic continuous glucose monitoring systems and extended-wear infusion set dublin, june 1, 2021 /prnewswire/ --  medtronic plc  (nyse:mdt), the global leader in medical technology, today announced its virtual participation at the 14th international conference on advanced technologies & treatments for diabetes (attd), taking place june 2-5, 2021. medtronic will showcase clinically meaningful outcomes associated with the company's comprehensive product portfolio and future technologies, as well as customer-centric support and services provided in a remote environment during the covid-19 pandemic, including onboarding and training for healthcare providers and patients.
MDT Ratings Summary
MDT Quant Ranking